Results 191 to 200 of about 93,237 (289)

First documented case of imported human babesiosis in Honduras: Diagnostic challenges with malaria falciparum. [PDF]

open access: yesIJID Reg
Chaver L   +9 more
europepmc   +1 more source

Acyclic Nucleoside Phosphonates As Potential Inhibitors of Plasmodium Falciparum Egress

open access: yesChemistry – A European Journal, Volume 31, Issue 69, December 9, 2025.
Exploration of the chemistry of acyclic nucleoside phosphonates allowed us to study structural diversity from the hit compound; biological evaluation and molecular docking were performed to decipher key interactions with the putative target. Abstract The emergence of drug‐resistant Plasmodium strains requires the development of novel antimalarial ...
Thomas Cheviet   +6 more
wiley   +1 more source

Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan. [PDF]

open access: yesMalar J
Qurashi B   +17 more
europepmc   +1 more source

Most autophagic cell death studies lack evidence of causality

open access: yesFEBS Open Bio, Volume 15, Issue 12, Page 1977-1986, December 2025.
Of 104 studies claiming autophagic cell death (ACD), only 13 demonstrated both causality and exclusion of apoptosis to confirm true ACD. Most studies relied on correlation‐level data or measured autophagy in isolation, revealing pervasive methodological shortcomings.
Ali Burak Özkaya, Yasmin Ghaseminejad
wiley   +1 more source

Photonic Nanomaterials for Wearable Health Solutions

open access: yesAdvanced Materials, Volume 37, Issue 49, December 10, 2025.
This review discusses the fundamentals and applications of photonic nanomaterials in wearable health technologies. It covers light‐matter interactions, synthesis, and functionalization strategies, device assembly, and sensing capabilities. Applications include skin patches and contact lenses for diagnostics and therapy. Future perspectives emphasize AI‐
Taewoong Park   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy